A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says its approach could also have applications in other disorders.
The proceeds are said to be used to finish a clinical registry trial of its portable neuromodulation stimulator in treating traumatic brain injury.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Helius Medical Technologies and the U.S. Army Medical Research and Materiel Command have announced a clinical trial for a traumatic brain injury device, and India is asking for $99.3M from Nestle after food scare involving Maggi noodles.